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ETATE-OF-THE-ART PAPER173Evaluating Coronary Physiology Prior to Percutaneous Coronary InterventionPlane 1
Plane 2
Severe narrowings?
Why does the angiogram fail? orton J. Kern, Habib Samady
ern and Samady review the physiologic rationale and the clinical data which suggest that stable
oronary stenoses be evaluated for physiologic significance prior to performing revascularization.
hey note the limits of angiographic visualization, and review how lengthy moderate stenoses may
estrict flow more than short, high-grade lesions. Most of the paper reviews the clinical literature
nd finds significant support for only performing revascularization if the fractional flow reserve is
educed, typically 0.75. This review recommends that coronary angiography and coronary
hysiology be integrated for optimal patient outcomes.CLINICAL RESEARCH NTERVENTIONAL CARDIOLOGY186MSCT, TTE, or TEE to Measure the Aortic Annulus Prior to TAVIavid Messika-Zeitoun, Jean-Michel Serfaty, Eric Brochet, Gregory Ducrocq, Laurent Lepage,
elphine Detaint, Fabien Hyafil, Dominique Himbert, Nicoletta Pasi, Jean-Pierre Laissy,
ernard Iung, Alec Vahanian
essika-Zeitoun and colleagues compared the measurements of the aortic annulus obtained
ith 3 different imaging modalities: transthoracic echocardiography (TTE), transesophageal
chocardiography (TEE), and multislice computed tomography (MSCT). There were strong
orrelations between the echocardiographic methods, but less for comparisons between
SCT and either TEE or TTE. The choice of valve prosthesis size, or the feasibility of
erforming transcatheter aortic valve implantation (TAVI), would have been different in 17%
f patients if TTE measurements were used instead of TEE, and for 40% if MSCT
easurements were used. In this group of patients referred for TAVI, measurements of the
ortic annulus using TTE, TEE, and MSCT are not identical, and the method used has
mportant potential clinical implications.
ditorial Comment: E. Murat Tuzcu, Samir R. Kapadia, Paul Schoenhagen, p. 195(continued on page A-26)
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pIPID-LOWERING AND STROKE198Cholesterol Lowering and the Risk of Strokeaffaele De Caterina, Marco Scarano, RosaMaria Marfisi, Giuseppe Lucisano, Francesco Palma,
lfonso Tatasciore, Roberto Marchioli
e Caterina and colleagues performed a comprehensive meta-analysis of randomized clinical
rials reporting the effects of cholesterol-lowering treatments on stroke. The studies reviewed
ncluded over 250,000 subjects with almost 1 million person-years of exposure. The odds ratio
OR) for stroke in actively-treated groups versus controls was 0.88. While statins decreased
he risk of total stroke significantly (OR: 0.85), the benefit of nonstatin interventions was
maller and not statistically significant (diet OR: 0.92, fibrates OR: 0.98, other treatments
R: 0.81). Each 1% reduction of total cholesterol predicted a 0.8% relative risk reduction of
troke. These results show that statins effectively decrease the risk of stroke, and their benefit
s proportional to the extent in reduction of total and low-density lipoprotein cholesterol.EART FAILURE213Anthracycline-Induced Cardiomyopathy CMEaniela Cardinale, Alessandro Colombo, Giuseppina Lamantia, Nicola Colombo, Maurizio Civelli,
aia De Giacomi, Mara Rubino, Fabrizio Veglia, Cesare Fiorentini, Carlo M. Cipolla
he natural history of anthracycline-induced cardiomyopathy (AC-CMP), as well as its
esponse to modern heart failure (HF) therapy, remains poorly defined. Cardinale and
olleagues report on 201 consecutive patients with a left ventricular ejection fraction (LVEF)
45% presumably due to AC-CMP. Enalapril and, when possible, carvedilol were promptly
nitiated after detection of LVEF reduction, and serial measurements were then obtained.
orty-two percent of patients had improvement of their LVEF to 50%, another 13% had
heir LVEF improve 10% but still remained 50%, and 45% had no improvement. The
ercentage of responders progressively decreased as the time from the end of chemotherapy to
he start of HF treatment increased. In patients developing AC-CMP, LVEF recovery may
e achieved when cardiac dysfunction is detected early and modern HF treatment is initiated
romptly.(continued on page A-32)
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pARDIAC IMAGING221Normal Stress-Only SPECT Predicts Low Risku Min Chang, Faisal Nabi, Jiaqiong Xu, Umara Raza, John J. Mahmarian
hang and colleagues determined the long-term mortality for all subjects who had a normal
ingle-photon emission computed tomography (SPECT) perfusion study and then compared
utcomes between those who had a stress-only study and those who had both rest and stress
maging. The unadjusted annual mortality rate in patients who had a normal SPECT using a
tress-only protocol was lower than in those who required additional rest imaging, but there
ere no significant differences after adjustment for baseline clinical characteristics. The stress-
nly group received a 61% lower radiopharmaceutical dosage. Patients determined to have a
ormal SPECT based on stress imaging alone have a similar mortality rate as those who have
normal SPECT based on evaluation of both stress and rest images and have a much lower
adiation exposure.ditorial Comment: Ami E. Iskandrian, p. 231THNICITY AND LV HYPERTROPHY234Some Hispanics Appear to Be More Susceptible to Developing LVHarlos J. Rodriguez, Ana V. Diez-Roux, Andrew Moran, Zhezhen Jin, Richard A. Kronmal, Joao Lima,
hunichi Homma, David A. Bluemke, R. Graham Barr
odriguez and colleagues examined the prevalence of left ventricular hypertrophy
LVH) and left ventricular (LV) remodeling patterns within Hispanic subgroups
ompared with non-Hispanic whites. Cardiac magnetic resonance imaging was per-
ormed in over 1,000 Hispanics who self-reported their ancestry as Mexican, Carib-
ean, or Central/South American. LVH was defined as the upper 95th percentile of
ndexed LV mass in a healthy reference population. Hispanic subgroups were more
ikely to have LVH than non-Hispanic whites after adjustment for hypertension and
ther covariates (Caribbean-origin Hispanics  odds ratio [OR]: 1.8; Mexican-origin
ispanics  OR: 2.2; Central/South Americans  OR: 1.5). All Hispanic subgroups
ad a higher prevalence of concentric and eccentric hypertrophy compared with non-
ispanic whites. Differences among Hispanic subgroups regarding LVH and LV re-
odeling should be taken into account when evaluating cardiovascular risk in this
opulation.(continued on page A-34)
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EIOMARKERS243Soluble ST2 Is Marker for Predicting Post-MI Recoveryobin A. P. Weir, Ashley M. Miller, Grace E. J. Murphy, Suzanne Clements, Tracey Steedman,
ohn M. C. Connell, Iain B. McInnes, Henry J. Dargie, John J. V. McMurray
his study by Weir and colleagues assessed the relationship between serum concentrations of
he soluble interleukin-1 receptor family member ST2 (sST2) and serial change in left
entricular (LV) function following acute myocardial infarction (AMI) in 100 subjects with
V dysfunction early after AMI. Median sST2 decreased from 263 pg/ml at baseline to 140
g/ml at 24 weeks. sST2 correlated significantly with LV ejection fraction both at baseline
nd at 24 weeks. sST2 was significantly higher in those with greater infarct transmurality and
ndocardial extent, and in the presence of microvascular obstruction. Measurement of sST2
arly after AMI assists in the prediction of medium-term LV functional recovery.ditorial Comment: Stephanie A. Moore, James L. Januzzi, Jr, p. 251
